Table 2 Design matrix of hypoxia/cisplatin treatments
From: Identifying novel hypoxia-associated markers of chemoresistance in ovarian cancer
Pre-treatment | Treatment Day 1 | Treatment Day 2 | Treatment Day 3 |
|---|---|---|---|
|  | (0 – 24 h) | (24 – 48 h) | (48 – 72 h) |
Normoxia | Normoxia | Normoxia | Normoxia |
Normoxia | Hypoxia | Hypoxia | Hypoxia |
Normoxia | Normoxia | Hypoxia | Hypoxia |
Normoxia | Normoxia | Normoxia | Hypoxia |
4Â hours hypoxia | Normoxia | Normoxia | Normoxia |
4Â hours hypoxia | Hypoxia | Hypoxia | Hypoxia |
5Â days hypoxia | Normoxia | Normoxia | Normoxia |
5Â days hypoxia | Hypoxia | Hypoxia | Hypoxia |